Lv5
1430 积分 2024-03-04 加入
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC
2天前
已完结
PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers
15天前
已关闭
A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair
1个月前
已完结
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21
1个月前
已完结
Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation
3个月前
已完结
Recent advances in B-RAF inhibitors as anticancer agents
3个月前
已完结
A Comprehensive Review of Targeting RAF Kinase in Cancer Targeting RAF Kinase in Cancer
3个月前
已完结
Novel Quinoline‐Based RAF Inhibitors: A Comprehensive Review on Synthesis, SAR and Molecular Docking Studies
3个月前
已关闭
An overview of RAF kinases and their inhibitors (2019-2023)
3个月前
已完结
An updated literature on BRAF inhibitors (2018–2023)
3个月前
已完结
皖公网安备34019202002308
